Praised as ‘highly professional, service-oriented, with the ability to find solutions’, Meitar Law Offices handles class actions, restrictive arrangements, and administrative fines cases before the ICA. ’Top-notch antitrust partner’ and former ICA criminal prosecutor Niva Barg Livnat leads the practice and Liat Hertzka specialises in merger controls, often assisting multinational law firms on large-scale cross-border M&A deals.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘I have been impressed with their team, their dedication to client service, and their cooperative approach to work for the client.’
‘Liat Hertka is my strongest contact, a very good antitrust/competition lawyer, who is great to work with. Niva Bar Livnat is another top-notch antitrust partner who is very bright.'
‘Extremely professional and knowledgeable.'
‘The team at Meitar Law firm is highly professional, service-oriented, with the ability to find solutions. Their availability is excellent, their knowledge is comprehensive, and they are very helpful and pleasant to work with. This is relevant to our interactions with all the individuals we work with on these matters in the department.’
Key clients
- Robert Bosch GmbH
- MAN Truck and Bus AG
- GlaxoSmithKline Israel and GlaxoSmithKline plc
- Energean Oil & Gas plc., Energean Israel Limited
- Stratasys Inc
- BP p.l.c
- GAON Group Ltd
- Wolfman Industries
- Nesher
- Bank Leumi Ltd
Work highlights
Representing Bosch on a Motion to Certify a Class Action which was filed to the Centre District Court on September 2020 against Bosch regarding their part in the "Spark Plug Cartel".
Representation of MAN in a motion to certify a class action that was filled to the Tel Aviv District Court in October 2016, by a small company on behalf of the whole class, against MAN and other truck manufacturers.
Representation of GlaxoSmithKline Israel and GlaxoSmithKline plc in a claim filed against them by Unipharm Ltd. The claim, filed in 2011, focused on the allegation that the GSK companies applied for a patent in Israel in connection with the active ingredient in the Seroxat drug in order to harm competition and to deter Unipharm from producing and marketing a generic drug for Seroxat (Paxxet) in Israel.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Niva Barg Livnat
Other key lawyers
Liat Hertzka